Barinthus Biotherapeutics Stock (NASDAQ:VACC)


ForecastOwnershipChart

Previous Close

$4.49

52W Range

$1.64 - $5.10

50D Avg

$3.14

200D Avg

$2.58

Market Cap

$192.73M

Avg Vol (3M)

$731.88K

Beta

-0.27

Div Yield

-

VACC Company Profile


Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. The company's therapeutic programs include VTP-300, which is in Phase 1/2a clinical trial for the treatment of chronic hepatitis B infection; VTP-200 that is in Phase 1/2a clinical trial for the treatment of human papilloma virus infection; VTP-850, which is in Phase 1/2 clinical trial for the treatment of prostate cancer; and VTP-600 that is in Phase 1/2a clinical trial for the treatment of non-small cell lung cancer. Its prophylactic programs include VTP-400, which is in preclinical stage for the prevention of herpes zoster or shingles; VTP-500 that has completed Phase 1 clinical trial for the prevention of Middle East respiratory syndrome; and Vaxzevria, a prophylactic vaccine for the prevention of COVID-19 infection. The company was formerly known as Vaccitech Rx Limited and changed its name to Vaccitech plc in March 2021. Vaccitech plc was founded in 2016 and is headquartered in Oxford, the United Kingdom.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

Yes

Country

GB

Employees

33

IPO Date

Apr 30, 2021

Website

VACC Performance


Peer Comparison


TickerCompany
CYTCyteir Therapeutics, Inc.
MGTADianthus Therapeutics, Inc.
TALSTourmaline Bio, Inc.
CGEMCullinan Oncology, Inc.
RVMDRevolution Medicines, Inc. Warrant
ACHLAchilles Therapeutics plc
VORVor Biopharma Inc.
EWTXEdgewise Therapeutics, Inc.
STOKStoke Therapeutics, Inc.
CTMXCytomX Therapeutics, Inc.
SPROSpero Therapeutics, Inc.
CSBRChampions Oncology, Inc.
GRPHLENZ Therapeutics, Inc.
TYRATyra Biosciences, Inc.
CCCCC4 Therapeutics, Inc.
ASMBAssembly Biosciences, Inc.
DSGNDesign Therapeutics, Inc.
MNOVMediciNova, Inc.
THRDThird Harmonic Bio, Inc.
ANEBAnebulo Pharmaceuticals, Inc.
MOLNMolecular Partners AG
NLTXNeurogene Inc.
ACETAdicet Bio, Inc.
TILInstil Bio, Inc.